Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2025-03-31
• Last 15 days FTD volume: NZ$8.78 M
• Last 3 months FTD volume: NZ$16.56 M
• Last year FTD volume: NZ$16.56 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	NZ$9.92 M	NZ$35.82 M	🇺🇸 USA
Royalty Pharma RPRX	NZ$16.49 M	NZ$42.86 M	🇬🇧 UK
Palatin Technologies PTN	NZ$0.67 M	NZ$3.54 M	🇺🇸 USA
Eli Lilly LLY	NZ$47.82 M	NZ$0.19 B	🇺🇸 USA
AbbVie ABBV	NZ$23.9 M	NZ$0.21 B	🇺🇸 USA
Pfizer PFE	NZ$33.22 M	NZ$0.35 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	NZ$0.25 M	NZ$4.58 M	🇺🇸 USA
Athersys ATHX	NZ$0.09 M	NZ$0.71 M	🇺🇸 USA